Sort
261,768 grants matching “gene therapy”
Biomarker Prediction of Gleason Upgrading
$1,050,970Bruce J Trock · Johns Hopkins University · RC2 · FY2010 · CA
NHGRI/DIR Genetic Counseling Training Program
$1,050,889Barbara Bowles Biesecker · National Human Genome Research Institute · ZIE · FY2017 · HG
Basic Research Support for the CCR
$1,050,724Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Recombinant AAV for Correction of Genetic Abnormalities
$1,050,549Barry J. Byrne · University Of Florida · P01 · FY2008 · DK
Molecular and Cellular Mechanisms of Vascular Anomalies
$1,050,476Harvard University (Medical School) · P01 · FY2004 · AR
Human Polycystic Kidney Disease
$1,050,412University Of Colorado Denver · P01 · FY2004 · DK
Defining the biological relevance of HIV specific HLA-E restricted CD8 T cell responses
$1,050,409Paul A. Goepfert · University Of Alabama At Birmingham · R01 · FY2022 · AI
Genetic Bone Disorders-Autosomal Recessive OI
$1,050,383Joan C Marini · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2016 · HD
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease
$1,050,306Jeremy H. Herskowitz · University Of Alabama At Birmingham · R01 · FY2022 · AG
Pathogenesis of Parenteral Viral Hepatitis
$1,050,189Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Discovery of B. pseudomallei therapeutics for Biodefense
$1,050,163Donald T Moir · Microbiotix, Inc · R44 · FY2008 · AI
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
$1,050,159Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
IL-6 Trans-signaling increases vulnerability to Postoperative Cognitive Decline in Aging and Alzheimers Disease
$1,050,037Mervyn Maze · University Of California, San Francisco · R01 · FY2025 · AG
Precision microRNA medicine in cancer
$1,050,000Frank J. Slack · Beth Israel Deaconess Medical Center · R35 · FY2025 · CA
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
$1,050,000Alex Toker · Beth Israel Deaconess Medical Center · R35 · FY2025 · CA
Precision microRNA medicine in cancer
$1,050,000Frank J. Slack · Beth Israel Deaconess Medical Center · R35 · FY2019 · CA
Precision microRNA medicine in cancer
$1,050,000Frank J. Slack · Beth Israel Deaconess Medical Center · R35 · FY2021 · CA
Deciphering the physiological role and interplay between ubiquitination and phosphorylation pathways to guide targeted cancer therapies
$1,050,000Wenyi Wei · Beth Israel Deaconess Medical Center · R35 · FY2021 · CA
Precision microRNA medicine in cancer
$1,050,000Frank J. Slack · Beth Israel Deaconess Medical Center · R35 · FY2020 · CA
Novel biologic to treat chemotherapy-induced neuropathic pain
$1,049,997Yakov Kogan · Raft Pharmaceuticals, Llc · R44 · FY2023 · CA
Novel, Non-hormonal Therapeutic for Endometriosis
$1,049,997Tanya Christineh Petrossian · Endomet Biosciences, Inc · R44 · FY2022 · HD
A Novel Bispecific Antibody for the Treatment of Idiopathic Pulmonary Fibrosis
$1,049,994Neil A Fanger · Virtici, Llc · R44 · FY2024 · HL
NATIONAL GENE VECTOR LABORATORY
$1,049,938Indiana Univ-Purdue Univ At Indianapolis · U42 · FY2001 · RR
Advancing a Candidate Polyclonal Antibody Therapy for Hantavirus Disease
$1,049,794Jay Williams Hooper · Geneva Foundation · R01 · FY2020 · AI
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
$1,049,779Thomas M Roberts · Dana-Farber Cancer Inst · R35 · FY2020 · CA